Actively Recruiting
A Cohort Study of Uterine Malignancies
Led by Women's Hospital School Of Medicine Zhejiang University · Updated on 2025-07-17
6200
Participants Needed
1
Research Sites
260 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This research aims to explore the relationship between cervical cancer and endometrial cancer with factors such as demographic information, behavior and lifestyle, pregnancy-related factors, and disease history. It also studies the factors that affect the prognosis of these cancers. Additionally, biological samples will undergo omics testing to identify diagnostic markers and prognostic biomarkers for these uterine malignancies. This is a prospective observational study with no intervention, meaning participants will not receive any specific treatment as part of the study. The study involves enrolling women diagnosed for the first time with cervical or endometrial cancer, as well as women attending health check-ups, with informed consent. Participants are observed over time to gather data relevant to cancer progression and prognosis. Participants will be involved in regular assessments and data collection related to their health and cancer status. The primary outcome measure is progression-free survival (PFS) monitored over 60 months. Researchers will collect and analyze biological specimens for biomarker identification. The study will continue until December 2030, with no experimental treatments administered, focusing on observation and follow-up of participants.
CONDITIONS
Brief Title
A Cohort Study of Uterine Malignancies
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 20-75 years
- Women diagnosed with cervical cancer or endometrial cancer for the first time with a definite pathological diagnosis
- Women attending a health check-up
- Able to provide informed consent and sign the consent form
You will not qualify if you...
- Unable to cooperate with investigations due to mental disorders or cognitive impairment
- Diagnosis of cancer other than cervical or endometrial cancer
- Previous hysterectomy or pelvic radiation therapy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 60 months
Participants are observed over time to monitor progression free survival and other health outcomes.
Periodic visits as part of routine health check-ups
Trial Site Locations
Total: 1 location
1
Women's hospital school of medicine zhejiang university
Hangzhou, Zhejiang, China, 310000
Actively Recruiting
Research Team
H
Hui Wang, PhD
X
Xiao Li, PhD
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here